Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;53(4):503-7.
doi: 10.1002/mus.25036. Epub 2016 Feb 22.

A protocol to develop clinical guidelines for inclusion-body myositis

Katherine L Jones  1 , Thomas Sejersen  2 , Anthony A Amato  3 , David Hilton-Jones  4 , Jens Schmidt  5 , Amanda C Wallace  6 , Umesh A Badrising  7 , Michael R Rose  1 ; IBM Guideline Development Group
Affiliations
Review

A protocol to develop clinical guidelines for inclusion-body myositis

Katherine L Jones et al. Muscle Nerve. 2016 Apr.

Abstract

Introduction: Inclusion-body myositis (IBM) is a late-onset idiopathic inflammatory myopathy associated with selective and progressive muscle weakness and atrophy. Current clinical management of IBM is largely supportive due to its uncertain etiology and lack of effective treatment. Establishing a consensus of opinion on questions relating to diagnosis and management of IBM is expected to help reduce inconsistencies in the care and resources allocated to those living with this condition.

Methods: A protocol has been developed to produce best practice clinical guidelines for IBM based on a combination of published research and expert consensus.

Conclusions: In this study we describe the proposed protocol for developing methods for producing robust and transparent clinical guidance on aspects of diagnosis, drug treatment, physical and practical management, respiration, nutrition and cardiac management, psychosocial management, and multidisciplinary care.

Keywords: IBM; diagnosis; guidelines; management; protocol.

PubMed Disclaimer

References

    1. Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci 2008;15:1350–1353. - PubMed
    1. Cox FM, Reijnierse M, van Rijswijk CS, Wintzen AR, Verschuuren JJ, Badrising UA. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxford, England) 2011;50:1153–1161. - PubMed
    1. Phillips BA, Cala LA, Thickbroom GW, Melsom A, Zilko PJ, Mastaglia FL. Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study. Muscle Nerve 2001;24:1526–1534. - PubMed
    1. Hiscock A, Dewar L, Parton M, Machado P, Hanna M, Ramdharry G. Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision. Physiotherapy 2014;100:61–65. - PubMed
    1. Sadjadi R, Rose MR, and the Muscle Study Group . What determines quality of life in inclusion body myositis? J Neurol Neurosurg Psychiatry 2010;81:1164–1166. - PubMed

Publication types

MeSH terms